NMS Group

Company

NMS Group develops one asset, in phase 1 (NMS-03597812 in multiple myeloma). Mostly small molecule.

1
Asset
Furthest stage
Phase 1
1
Trial
0
Signals

Pipeline

1

Full company profiles: pipeline, trials, funding and people.

See Pro

Subsidiaries

1

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Similar companies6

Intelligence